John D. Parker

14.5k total citations · 1 hit paper
243 papers, 9.5k citations indexed

About

John D. Parker is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Surgery. According to data from OpenAlex, John D. Parker has authored 243 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Cardiology and Cardiovascular Medicine, 58 papers in Physiology and 30 papers in Surgery. Recurrent topics in John D. Parker's work include Heart Rate Variability and Autonomic Control (51 papers), Nitric Oxide and Endothelin Effects (41 papers) and Cardiovascular Function and Risk Factors (39 papers). John D. Parker is often cited by papers focused on Heart Rate Variability and Autonomic Control (51 papers), Nitric Oxide and Endothelin Effects (41 papers) and Cardiovascular Function and Risk Factors (39 papers). John D. Parker collaborates with scholars based in Canada, United States and Italy. John D. Parker's co-authors include Gary E. Newton, Tommaso Gori, John S. Floras, T. Douglas Bradley, Eduardo Ribeiro de Azevêdo, John O. Parker, Fabia S. Fitzgerald, Don D. Sin, Susanna Mak and Abdul Al‐Hesayen and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

John D. Parker

237 papers receiving 9.1k citations

Hit Papers

Risk Factors for Central and Obstructive Sleep Apnea in 4... 1999 2026 2008 2017 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Parker Canada 50 4.8k 3.2k 1.7k 1.3k 1.1k 243 9.5k
Kenneth Caidahl Sweden 53 5.0k 1.0× 2.3k 0.7× 1.5k 0.9× 728 0.6× 1.5k 1.3× 323 11.1k
Paul Hjemdahl Sweden 56 5.8k 1.2× 1.9k 0.6× 1.0k 0.6× 584 0.4× 1.7k 1.6× 359 11.7k
Walter N. Kernan United States 38 4.2k 0.9× 3.2k 1.0× 4.2k 2.5× 1.6k 1.2× 2.1k 1.9× 96 16.7k
Péter Vollenweider Switzerland 60 2.6k 0.5× 5.3k 1.7× 1.2k 0.7× 2.3k 1.7× 1.4k 1.2× 363 14.6k
David O. Warner United States 60 3.2k 0.7× 2.6k 0.8× 2.2k 1.3× 448 0.3× 3.1k 2.8× 374 13.3k
Pasquale Strazzullo Italy 53 3.0k 0.6× 2.4k 0.7× 1.4k 0.8× 1.1k 0.9× 1.0k 0.9× 287 14.1k
William G. Haynes United States 57 4.2k 0.9× 6.3k 2.0× 1.3k 0.8× 4.3k 3.3× 1.6k 1.4× 190 13.0k
Gavin Lambert Australia 76 10.6k 2.2× 4.2k 1.3× 835 0.5× 2.2k 1.7× 2.7k 2.4× 401 19.2k
Braxton D. Mitchell United States 67 4.0k 0.8× 3.5k 1.1× 631 0.4× 1.1k 0.9× 3.0k 2.7× 375 18.3k
Joseph Francis United States 59 3.5k 0.7× 1.4k 0.4× 1.3k 0.8× 860 0.7× 1.3k 1.1× 189 14.5k

Countries citing papers authored by John D. Parker

Since Specialization
Citations

This map shows the geographic impact of John D. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Parker more than expected).

Fields of papers citing papers by John D. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Parker. The network helps show where John D. Parker may publish in the future.

Co-authorship network of co-authors of John D. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Parker. A scholar is included among the top collaborators of John D. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Parker. John D. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konstam, Marvin A., James E. Udelson, Douglas L. Mann, et al.. (2024). Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results. Journal of Cardiac Failure. 30(1). 313–313. 2 indexed citations
2.
Kasai, Takatoshi, Luigi Taranto‐Montemurro, Dai Yumino, et al.. (2020). Inverse Relationship of Subjective Daytime Sleepiness to Mortality in Heart Failure Patients with Sleep Apnoea. ESC Heart Failure. 7(5). 2448–2454. 9 indexed citations
3.
Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2017). Systolic Blood Pressure Reduction During the First 24 H in Acute Heart Failure Admission: Friend or Foe?. European Journal of Heart Failure. 20(2). 317–322. 17 indexed citations
5.
Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2014). Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study. European Journal of Heart Failure. 16(12). 1362–1371. 23 indexed citations
6.
Diego, Carlos De, Fuhua Chen, Yuanfang Xie, et al.. (2010). Anisotropic conduction block and reentry in neonatal rat ventricular myocyte monolayers. American Journal of Physiology-Heart and Circulatory Physiology. 300(1). H271–H278. 11 indexed citations
7.
Tanous, David, Samuel C. Siu, Jennifer Mason, et al.. (2010). B-Type Natriuretic Peptide in Pregnant Women With Heart Disease. Journal of the American College of Cardiology. 56(15). 1247–1253. 127 indexed citations
8.
Gori, Tommaso, Saverio Dragoni, Giuseppe Di Stolfo, et al.. (2009). Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. American Journal of Physiology-Heart and Circulatory Physiology. 298(2). H340–H345. 31 indexed citations
10.
Al‐Hesayen, Abdul, John S. Floras, & John D. Parker. (2006). The Effects of Intravenous Sildenafil on Hemodynamics and Cardiac Sympathetic Activity in Chronic Human Heart Failure. European Journal of Heart Failure. 8(8). 864–868. 26 indexed citations
11.
Kubo, Toshihiko, John D. Parker, Eduardo Ribeiro de Azevêdo, et al.. (2005). Vagal Heart Rate Responses to Chronic Beta-Blockade in Human Heart Failure Relate to Cardiac Norepinephrine Spillover. European Journal of Heart Failure. 7(5). 878–881. 23 indexed citations
12.
Cowburn, Peter J., et al.. (2005). Contrast Nephropathy Post Cardiac Resynchronization Therapy: An Under-Recognized Complication with Important Morbidity. European Journal of Heart Failure. 7(5). 899–903. 27 indexed citations
13.
Cowburn, Peter J., et al.. (2005). Cardiac Resynchronisation Therapy: An Option for Inotrope-Supported Patients with End-Stage Heart Failure?. European Journal of Heart Failure. 7(2). 215–217. 39 indexed citations
14.
Al‐Hesayen, Abdul, et al.. (2004). Selective Versus Nonselective β-Adrenergic Receptor Blockade in Chronic Heart Failure: Differential Effects on Myocardial Energy Substrate Utilization. European Journal of Heart Failure. 7(4). 618–623. 36 indexed citations
15.
Ryu, Ki Sung, et al.. (2001). Simultaneous Three Color Detection of Surface Antigen (My 7), Intracellular Antigen (c-myc), and DNA Content using Single Laser Flow Cytometry.. Korean Journal of Obstetrics & Gynecology. 40(1). 181–190. 1 indexed citations
16.
Sin, Don D., Fabia S. Fitzgerald, John D. Parker, et al.. (1999). Risk Factors for Central and Obstructive Sleep Apnea in 450 Men And Women with Congestive Heart Failure. American Journal of Respiratory and Critical Care Medicine. 160(4). 1101–1106. 833 indexed citations breakdown →
17.
Parker, John D., Dina Brooks, L. F. Kozar, et al.. (1999). Acute and Chronic Effects of Airway Obstruction on Canine Left Ventricular Performance. American Journal of Respiratory and Critical Care Medicine. 160(6). 1888–1896. 124 indexed citations
18.
Parker, John D., et al.. (1998). Diuretic Therapy in Angina Pectoris: Effects on Nitrate Tolerance and Exercise Performance. The American Journal of Cardiology. 81(1). 41A–43A. 1 indexed citations
19.
Parker, John D., et al.. (1993). Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. Journal of the American College of Cardiology. 21(6). 1445–1453. 45 indexed citations
20.
Stevenson, William G., et al.. (1993). Increasing catheter ablation lesion size by simultaneous application of radiofrequency current to two adjacent sites. American Heart Journal. 125(5). 1276–1284. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026